Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1995-05-24
1999-10-05
Ketter, James
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
4242341, 4242571, 4242581, 4242721, 435 693, 4353201, 536 235, 536 237, 5362372, A61K 3902, C12N 1511, C12N 1563
Patent
active
059619830
ABSTRACT:
This invention pertains to a complementation system for the selection and maintenance of expressed genes in bacterial hosts. The invention provides stable vectors which can be selected and maintained by complementation of chromosomal deletion mutations of purA (adenylosuccinate synthetase), obviating the use of antibiotic resistance genes. This system is useful in production organisms during fermentation and in live vaccine bacteria, such as attenuated Salmonella typhi. This system allows for selection of chromosomal integrants and for selection and stable plasmid maintenance in the vaccinated host without application of external selection pressure.
REFERENCES:
patent: 4550081 (1985-10-01), Stocker
patent: 4735801 (1988-04-01), Stocker
patent: 4760022 (1988-07-01), Molin et al.
patent: 4837151 (1989-06-01), Stocker
Cardenas et al. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. vol. 5 pp. 328-342 1992.
Deich et al. Cloning of genes encoding a 15,000-dalton peptidoglycan-asssociated outer membrane lipoprotein and an antigenically related 15,000-dalton protein from Haemophilus influenzae J. Bacteriol. vol. 170 489-498, 1988.
Reznikoff et al. E. coli promoters pp. 1-33 in Maximizing Gene Expression Reznikoff and Gold, Eds. Butterworths, Boston, 1986.
Davis et al. Microbiology, Second Edition, Harper and Row, Hagerstown Maryland pp. 357-358, 1973.
Wolfe and Smith, J. Biol. Chem. 263:19147-19153 (1988).
O'Callaghan, D. et al., Infection and Immunity 56:419-423 (Feb. 1988).
Nakayama, K. et al., Bio/Technology 6:693-697 (Jun. 1988).
Miwa, K. et al., Gene 31:275-277 (1984).
Gerdes, K., Bio/Technology 6:1402-1405 (Dec. 1988).
Niki, H. et al., J. Bacteriol. 170:5272-5278 (Nov. 1988).
Austin, S. et al., J. Bacteriol. 168:1010-1013 (Nov. 1986).
J. Hackett, "Salmonella-based Vaccines," Vaccine, 8:5-11 (1990).
M.M. Levine et al., Safety Infectivity, Immunogenicity, and In Vivo Stability of Two Attenuated Auxotriphic Mutant Strains of Salmonella Typhi, 541Ty and 543Ty, as Live Oral Vaccines In Humans, The Journal of Clinical Investigation, 79:888-902 (1987).
S.A. Wolfe and John M. Smith, Nucleotide Sequence an Analysis of the purA Gene Encoding Adenylosuccinate Synthetase of Escherichia coli K12, The Journal of Biological Chemistry, 263:19147-19153 (1988).
Bass et al., Over Production Purification, and Characterization of Adenylosuccinate Synthase from E. coli, Arch Biochem Biophy 256 (1): 335-342 (1987).
Sigwart et al., "Effect of a purA Mutation on Efficacy of Salmonella Live Vaccine Vector" Infect. Immun. 57 (6): 1858-1861 (1989).
Anilionis Algis
Brey Robert N.
Fulginiti James P.
Brusca John S.
Ketter James
Praxis Biologics, Inc.
LandOfFree
Stable pura vectors and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable pura vectors and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable pura vectors and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168442